Ferroptosis: A potential therapeutic target in autoimmune disease (Review)
- Authors:
- Liang Shen
- Xiaohan Wang
- Changlin Zhai
- Yunqing Chen
-
Affiliations: Department of Cardiology, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China, Department of Gastroenterology, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China, Department of Infectious Diseases, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China - Published online on: June 15, 2023 https://doi.org/10.3892/etm.2023.12067
- Article Number: 368
-
Copyright: © Shen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K and Possemato R: NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 551:639–643. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Lee JY, Nam M, Son HY, Hyun K, Jang SY, Kim JW, Kim MW, Jung Y, Jang E, Yoon SJ, et al: Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci USA. 117:32433–32442. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 16:1180–1191. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for protection against cardiomyopathy. Natl Acad Sci USA. 116:2672–2680. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Park MW, Cha HW, Kim J, Kim JH, Yang H, Yoon S, Boonpraman N, Yi SS, Yoo ID and Moon JS: NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases. Redox Biol. 41(101947)2021.PubMed/NCBI View Article : Google Scholar | |
|
Do Van B, Gouel F, Jonneaux A, Timmerman K, Gelé P, Pétrault M, Bastide M, Laloux C, Moreau C, Bordet R, et al: Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC. Neurobiol Dis. 94:169–178. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Hayter SM and Cook MC: Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 11:754–765. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cho JH and Gregersen PK: Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med. 365:1612–1623. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Lai B, Wu CH, Wu CY, Luo SF and Lai JH: Ferroptosis and autoimmune diseases. Front Immunol. 13(916664)2022.PubMed/NCBI View Article : Google Scholar | |
|
Fan J, Jiang T and He D: Emerging insights into the role of ferroptosis in the pathogenesis of autoimmune diseases. Front Immunol. 14(1120519)2023.PubMed/NCBI View Article : Google Scholar | |
|
Ohl K, Rauen T and Tenbrock K: Dysregulated neutrophilic cell death in SLE: A spotlight on ferroptosis. Signal Transduct Target Ther. 6(392)2021.PubMed/NCBI View Article : Google Scholar | |
|
Hu H, Chen Y, Jing L, Zhai C and Shen L: The link between ferroptosis and cardiovascular diseases: A novel target for treatment. Front Cardiovasc Med. 8(710963)2021.PubMed/NCBI View Article : Google Scholar | |
|
Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 575:688–692. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X, Anastasov N, Kössl J, et al: GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 6:41–53. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 575:693–698. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Iwasaki A and Medzhitov R: Control of adaptive immunity by the innate immune system. Nat Immunol. 16:343–353. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yang Y, Wang Y, Guo L, Gao W, Tang TL and Yan M: Interaction between macrophages and ferroptosis. Cell Death Dis. 13(355)2022.PubMed/NCBI View Article : Google Scholar | |
|
Stockwell BR and Jiang X: A physiological function for ferroptosis in tumor suppression by the immune system. Cell Metab. 30:14–15. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Akirav EM, Ruddle NH and Herold KC: The role of AIRE in human autoimmune disease. Nat Rev Endocrinol. 7:25–33. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Matsushita M, Freigang S, Schneider C, Conrad M, Bornkamm GW and Kopf M: T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med. 212:555–568. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al: CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 569:270–274. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yao Y, Chen Z, Zhang H, Chen C, Zeng M, Yunis J, Wei Y, Wan Y, Wang N, Zhou M, et al: Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat Immunol. 22:1127–1139. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Shaw J, Chakraborty A, Nag A, Chattopadyay A, Dasgupta AK and Bhattacharyya M: Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients. Eur J Haematol. 99:399–408. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Anupam K, Kaushal J, Prabhakar N and Bhatnagar A: Effect of redox status of peripheral blood on immune signature of circulating regulatory and cytotoxic T cells in streptozotocin induced rodent model of type I diabetes. Immunobiology. 223:586–597. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Muri J, Thut H, Bornkamm GW and Kopf M: B1 and marginal zone B cells but not follicular B2 cells require Gpx4 to prevent lipid peroxidation and ferroptosis. Cell Rep. 29:2731–2744.e4. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang D, Xie N, Gao W, Kang R and Tang D: The ferroptosis inducer erastin promotes proliferation and differentiation in human peripheral blood mononuclear cells. Biochem Biophys Res Commun. 503:1689–1695. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Yu B, Choi B, Li W and Kim DH: Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy. Nat Commun. 11(3637)2020.PubMed/NCBI View Article : Google Scholar | |
|
Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, Vedunova MV, Fimognari C, Bachert C, Coppieters F, et al: Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 8(e001369)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Z, Qiu X, Yan Y, Liang Q, Cai Y, Peng B, Xu Z and Xia F: Evaluation of ferroptosis-related gene AKR1C1 as a novel biomarker associated with the immune microenvironment and prognosis in breast cancer. Int J Gen Med. 14:6189–6200. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ, Zeh HJ, Kang R, Wang J and Tang D: Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 16:2069–2083. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li W, Feng G, Gauthier JM, Lokshina I, Higashikubo R, Evans S, Liu X, Hassan A, Tanaka S, Cicka M, et al: Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation. J Clin Invest. 129:2293–2304. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Hall SW and Cooke A: Autoimmunity and inflammation: Murine models and translational studies. Mamm Genome. 22:377–389. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Roh JS and Sohn DH: Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 18(e27)2018.PubMed/NCBI View Article : Google Scholar | |
|
Gong T, Liu L, Jiang W and Zhou R: DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 20:95–112. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Schaper F, Westra J and Bijl M: Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus. Mol Med. 20:72–79. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Boyapati RK, Dorward DA, Tamborska A, Kalla R, Ventham NT, Doherty MK, Whitfield PD, Gray M, Loane J, Rossi AG, et al: Mitochondrial DNA is a pro-inflammatory damage-associated molecular pattern released during active IBD. Inflamm Bowel Dis. 24:2113–2122. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Freire Boullosa L, Van Loenhout J, Flieswasser T, De Waele J, Hermans C, Lambrechts H, Cuypers B, Laukens K, Bartholomeus E, Siozopoulou V, et al: Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer. Redox Biol. 42(101949)2021.PubMed/NCBI View Article : Google Scholar | |
|
Liu M, Fan Y, Li D, Han B, Meng Y, Chen F, Liu T, Song Z, Han Y, Huang L, et al: Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 15:2084–2105. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Chen C, Wang D, Yu Y, Zhao T, Min N, Wu Y, Kang L, Zhao Y, Du L, Zhang M, et al: Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI. Cell Death Dis. 12(65)2021.PubMed/NCBI View Article : Google Scholar | |
|
Zhao YY, Lian JX, Lan Z, Zou KL, Wang WM and Yu GT: Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC. Oral Dis. 29:933–941. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Van Loenhout J, Freire Boullosa L, Quatannens D, De Waele J, Merlin C, Lambrechts H, Lau HW, Hermans C, Lin A, Lardon F, et al: Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma. Cells. 10(2936)2021.PubMed/NCBI View Article : Google Scholar | |
|
Martin-Sanchez D, Ruiz-Andres O, Poveda J, Carrasco S, Cannata-Ortiz P, Sanchez-Niño MD, Ruiz Ortega M, Egido J, Linkermann A, Ortiz A and Sanz AB: Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. J Am Soc Nephrol. 28:218–229. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li X, Duan L, Yuan S, Zhuang X, Qiao T and He J: Ferroptosis inhibitor alleviates radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1. J Inflamm (Lond). 16(11)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhernakova A, Withoff S and Wijmenga C: Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol. 9:646–659. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH and Czaja AJ: Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice guidance and guidelines from the American association for the study of liver diseases. Hepatology. 72:671–722. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Deng G, Li Y, Ma S, Gao Z, Zeng T, Chen L, Ye H, Yang M, Shi H, Yao X, et al: Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress. Free Radic Biol Med. 148:151–161. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhu L, Chen D, Zhu Y, Pan T, Xia D, Cai T, Lin H, Lin J, Jin X, Wu F, et al: GPX4-regulated ferroptosis mediates S100-induced experimental autoimmune hepatitis associated with the Nrf2/HO-1 signaling pathway. Oxid Med Cell Longev. 2021(6551069)2021.PubMed/NCBI View Article : Google Scholar | |
|
Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, et al: 2015 American college of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 68:1–26. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, et al: 2021 American college of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 73:1108–1123. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Wu J, Feng Z, Chen L, Li Y, Bian H, Geng J, Zheng ZH, Fu X, Pei Z, Qin Y, et al: TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models. Nat Commun. 13(676)2022.PubMed/NCBI View Article : Google Scholar | |
|
Floros KV, Cai J, Jacob S, Kurupi R, Fairchild CK, Shende M, Coon CM, Powell KM, Belvin BR, Hu B, et al: MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system Xc-/glutathione axis. Cancer Res. 81:1896–1908. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ling H, Li M, Yang C, Sun S, Zhang W, Zhao L, Xu N, Zhang J, Shen Y, Zhang X, et al: Glycine increased ferroptosis via SAM-mediated GPX4 promoter methylation in rheumatoid arthritis. Rheumatology (Oxford). 61:4521–4534. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Luo H and Zhang R: Icariin enhances cell survival in lipopolysaccharide-induced synoviocytes by suppressing ferroptosis via the Xc-/GPX4 axis. Exp Ther Med. 21(72)2021.PubMed/NCBI View Article : Google Scholar | |
|
Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, et al: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford). 57:e1–e45. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Tsokos GC, Lo MS, Costa Reis P and Sullivan KE: New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 12:716–730. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Indrakanti DL, Alvarado A, Zhang X, Birmingham DJ, Hinton A and Rovin BH: The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares. Lupus. 26:200–203. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Chen W, Li W, Zhang Z, Tang X, Wu S, Yao G, Li K, Wang D, Xu Y, Feng R, et al: Lipocalin-2 exacerbates lupus nephritis by promoting Th1 cell differentiation. J Am Soc Nephrol. 31:2263–2277. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Scindia Y, Wlazlo E, Ghias E, Cechova S, Loi V, Leeds J, Ledesma J, Helen C and Swaminathan S: Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis. Kidney Int. 98:100–115. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li P, Jiang M, Li K, Li H, Zhou Y, Xiao X, Xu Y, Krishfield S, Lipsky PE, Tsokos GC and Zhang X: Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol. 22:1107–1117. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ananthakrishnan AN: Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 12:205–217. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Guan Q: A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019(7247238)2019.PubMed/NCBI View Article : Google Scholar | |
|
Mayr L, Grabherr F, Schwärzler J, Reitmeier I, Sommer F, Gehmacher T, Niederreiter L, He GW, Ruder B, Kunz KTR, et al: Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease. Nat Commun. 11(1775)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu J, Liu S, Cui Z, Wang X, Ning T, Wang T, Zhang N, Xie S, Min L, Zhang S, et al: Ferrostatin-1 alleviated TNBS induced colitis via the inhibition of ferroptosis. Biochem Biophys Res Commun. 573:48–54. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Xu M, Tao J, Yang Y, Tan S, Liu H, Jiang J, Zheng F and Wu B: Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis. Cell Death Dis. 11(86)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Wang J, Li J, Zhu J, Wang R, Xi Q, Wu H, Shi T and Chen W: Astragalus polysaccharide prevents ferroptosis in a murine model of experimental colitis and human Caco-2 cells via inhibiting NRF2/HO-1 pathway. Eur J Pharmacol. 911(174518)2021.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Zhang P, Chen W and Chen G: Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2/HO-1 signaling pathway. Immunol Lett. 225:9–15. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, et al: ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Eur J Neurol. 25:215–237. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hemmer B, Archelos JJ and Hartung HP: New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci. 3:291–301. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Hu CL, Nydes M, Shanley KL, Morales Pantoja IE, Howard TA and Bizzozero OA: Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurochem. 148:426–439. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Jhelum P, Santos-Nogueira E, Teo W, Haumont A, Lenoël I, Stys PK and David S: Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination. J Neurosci. 40:9327–9341. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Stewart DA: NICE guideline for Parkinson's disease. Age Ageing. 36:240–242. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao X, et al: T cells from patients with Parkinson's disease recognize α-synuclein peptides. Nature. 546:656–661. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Thapa K, Khan H, Kanojia N, Singh TG, Kaur A and Kaur G: Therapeutic insights on ferroptosis in Parkinson's disease. Eur J Pharmacol. 930(175133)2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhang P, Chen L, Zhao Q, Du X, Bi M, Li Y, Jiao Q and Jiang H: Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson's disease. Free Radic Biol Med. 152:227–234. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P and Marsden CD: Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem. 52:1830–1836. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P and Marsden CD: Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem. 52:381–389. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Sofic E, Lange KW, Jellinger K and Riederer P: Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett. 142:128–130. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Zuo Y, Xie J, Li X, Li Y, Thirupathi A, Zhang J, Yu P, Gao G, Chang Y and Shi Z: Ferritinophagy-mediated ferroptosis involved in paraquat-induced neurotoxicity of dopaminergic neurons: Implication for neurotoxicity in PD. Oxid Med Cell Longev. 2021(9961628)2021.PubMed/NCBI View Article : Google Scholar | |
|
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM and Ashcroft DM: Global Psoriasis Atlas. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ. 369(m1590)2020.PubMed/NCBI View Article : Google Scholar | |
|
Arbiser JL, Bonner MY, Ward N, Elsey J and Rao S: Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer. Biochim Biophys Acta Gen Subj. 1862:2518–2527. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Shou Y, Yang L, Yang Y and Xu J: Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis. 12(1009)2021.PubMed/NCBI View Article : Google Scholar | |
|
Atkinson MA and Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 331:1428–1436. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Zang H, Wu W, Qi L, Tan W, Nagarkatti P, Nagarkatti M, Wang X and Cui T: Autophagy inhibition enables Nrf2 to exaggerate the progression of diabetic cardiomyopathy in mice. Diabetes. 69:2720–2734. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ni T, Huang X, Pan S and Lu Z: Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. J Cell Mol Med. 25:9995–10007. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Li S, Zheng L, Zhang J, Liu X and Wu Z: Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 162:435–449. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Kim S, Kang SW, Joo J, Han SH, Shin H, Nam BY, Park J, Yoo TH, Kim G, Lee P and Park JT: Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis. 12(160)2021.PubMed/NCBI View Article : Google Scholar | |
|
Bruni A, Bornstein S, Linkermann A and Shapiro AMJ: Regulated cell death seen through the lens of islet transplantation. Cell Transplant. 27:890–901. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Krümmel B, Plötz T, Jörns A, Lenzen S and Mehmeti I: The central role of glutathione peroxidase 4 in the regulation of ferroptosis and its implications for pro-inflammatory cytokine-mediated beta-cell death. Biochim Biophys Acta Mol Basis Dis. 1867(166114)2021.PubMed/NCBI View Article : Google Scholar | |
|
Fudman EJ, Till GO and Fox IH: Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis. J Rheumatol. 14:686–691. 1987.PubMed/NCBI | |
|
Salvarani C, Baricchi R, Lasagni D, Boiardi L, Piccinini R, Brunati C, Macchioni P and Portioli I: Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis. Rheumatol Int. 16:45–48. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Lynch SG, Peters K and LeVine SM: Desferrioxamine in chronic progressive multiple sclerosis: A pilot study. Mult Scler. 2:157–160. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Lynch SG, Fonseca T and LeVine SM: A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis. Cell Mol Biol (Noisy-le-grand). 46:865–869. 2000.PubMed/NCBI | |
|
Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N and Romero-Ramos M: Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. Exp Neurol. 247:45–58. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Sweeney ME, Slusser JG, Lynch SG, Benedict SH, Garcia SL, Rues L and LeVine SM: Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects. Int Immunopharmacol. 11:1796–1801. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garçon G, Rouaix N, et al: Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid Redox Signal. 21:195–210. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Yang B, Hou S, Huang S, Li H and Li Y: Ferroptosis inhibitor regulates the disease progression of systematic lupus erythematosus mice model through Th1/Th2 ratio. Curr Mol Med: May 25, 2022 (Epub ahead of print). | |
|
Hinman A, Holst CR, Latham JC, Bruegger JJ, Ulas G, McCusker KP, Amagata A, Davis D, Hoff KG, Kahn-Kirby AH, et al: Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase. PLoS One. 13(e0201369)2018.PubMed/NCBI View Article : Google Scholar | |
|
Edmonds SE, Winyard PG, Guo R, Kidd B, Merry P, Langrish-Smith A, Hansen C, Ramm S and Blake DR: Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis. 56:649–655. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Aristotelous P, Stefanakis M, Pantzaris M, Pattichis CS, Calder PC, Patrikios IS, Sakkas GK and Giannaki CD: The effects of specific omega-3 and omega-6 polyunsaturated fatty acids and antioxidant vitamins on gait and functional capacity parameters in patients with relapsing-remitting multiple sclerosis. Nutrients. 13(3661)2021.PubMed/NCBI View Article : Google Scholar | |
|
Taghizadeh M, Tamtaji OR, Dadgostar E, Daneshvar Kakhaki R, Bahmani F, Abolhassani J, Aarabi MH, Kouchaki E, Memarzadeh MR and Asemi Z: The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial. Neurochem Int. 108:183–189. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kharaeva Z, Gostova E, De Luca C, Raskovic D and Korkina L: Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition. 25:295–302. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Odinak MM, Bisaga GN and Zarubina IV: New approaches to antioxidant therapy in multiple sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova. (Suppl):S72–S75. 2002.PubMed/NCBI(In Russian). | |
|
Miroliaee AE, Esmaily H, Vaziri-Bami A, Baeeri M, Shahverdi AR and Abdollahi M: Amelioration of experimental colitis by a novel nanoselenium-silymarin mixture. Toxicol Mech Methods. 21:200–208. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Peretz A, Siderova V and Nève J: Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scand J Rheumatol. 30:208–212. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Tarp U, Overvad K, Thorling EB, Graudal H and Hansen JC: Selenium treatment in rheumatoid arthritis. Scand J Rheumatol. 14:364–368. 1985.PubMed/NCBI View Article : Google Scholar | |
|
Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S and Islam F: Dose-dependent protective effect of selenium in rat model of Parkinson's disease: Neurobehavioral and neurochemical evidences. J Neurochem. 84:438–446. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Batooei M, Tahamoli-Roudsari A, Basiri Z, Yasrebifar F, Shahdoust M, Eshraghi A, Mehrpooya M and Ataei S: Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: A randomized, double blind clinical trial. Rev Recent Clin Trials. 13:132–138. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, Miklossy G, Jimah J, Doherty E, Tily H, et al: N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 64:2937–2946. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Zheng K, Dong Y, Yang R, Liang Y, Wu H and He Z: Regulation of ferroptosis by bioactive phytochemicals: Implications for medical nutritional therapy. Pharmacol Res. 168(105580)2021.PubMed/NCBI View Article : Google Scholar | |
|
Khojah HM, Ahmed S, Abdel-Rahman MS and Elhakeim EH: Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: A clinical study. Clin Rheumatol. 37:2035–2042. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Samsami-Kor M, Daryani NE, Asl PR and Hekmatdoost A: Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 46:280–285. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Samsamikor M, Daryani NE, Asl PR and Hekmatdoost A: Resveratrol supplementation and oxidative/anti-oxidative status in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 47:304–309. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Movahed A, Raj P, Nabipour I, Mahmoodi M, Ostovar A, Kalantarhormozi M and Netticadan T: Efficacy and safety of resveratrol in type 1 diabetes patients: A two-month preliminary exploratory trial. Nutrients. 12(161)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ghavipour M, Sotoudeh G, Tavakoli E, Mowla K, Hasanzadeh J and Mazloom Z: Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in rheumatoid arthritis patients. Eur J Clin Nutr. 71:92–96. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Petramfar P, Hajari F, Yousefi G, Azadi S and Hamedi A: Efficacy of oral administration of licorice as an adjunct therapy on improving the symptoms of patients with Parkinson's disease, A randomized double blinded clinical trial. J Ethnopharmacol. 247(112226)2020.PubMed/NCBI View Article : Google Scholar | |
|
Lin D, Zhang M, Luo C, Wei P, Cui K and Chen Z: Targeting ferroptosis attenuates inflammation, fibrosis, and mast cell activation in chronic prostatitis. J Immunol Res. 2022(6833867)2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhao T, Yang Q, Xi Y, Xie Z, Shen J, Li Z, Li Z and Qin D: Ferroptosis in rheumatoid arthritis: A potential therapeutic strategy. Front Immunol. 13(779585)2022.PubMed/NCBI View Article : Google Scholar |
